1-15 of 15 results for subject:"Eli Lilly"
Librarians' tools
- Search time
- 0.329 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:"Eli Lilly"
- We searched for
- subject_t:"Eli Lilly" OR subject_ses:17434
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
A briefing on the licensing, regulation and supply of new weight loss medications in England.
A briefing on the licensing, regulation and supply of new weight loss medications in England.
To ask the Secretary of State for Health and Social Care, if he will have discussions with (a) Eisai Co., Ltd and Biogen Inc. and (b) Eli Lilly and Company on the production of disease-modifying treatments for Alzheimer's disease in the UK.
To ask the Secretary of State for Health and Social Care, if he will have discussions with (a) Eisai Co., Ltd and Biogen Inc. and (b) Eli Lilly and Company on the production of disease-modifying treatments for Alzheimer's disease in the UK.
The Government deeply values its relationships with life science companies and is committed to getting treatments to National Health Service patients through our 10 Year Plan for the NHS. This will include a plan for procurement, giving a clearer route to getting products into the NHS, coupled with reformed incentive structures to drive innovation and faster regulatory approval for new technology and medicines. The Government engages regularly with companies on the production of disease-modifying treatments for Alzheimer's disease in the United Kingdom, such as those developed by Eisai, Biogen, and Eli Lilly, and where appropriate, ministers may be involved in this engagement.
On what dates since 28 Nov 1989 MAFF officials & members of veterinary products committee have met representatives of Eli Lilley; what matters were discussed
On what dates since 28 Nov 1989 MAFF officials & members of veterinary products committee have met representatives of Eli Lilley; what matters were discussed
When representatives from Eli Lilley & Monsanto last met members of Veterinary Products Committee
When representatives from Eli Lilley & Monsanto last met members of Veterinary Products Committee
When was last meeting with a representative for Eli Lilly; what was discussed; & are there plans for any future meetings.
When was last meeting with a representative for Eli Lilly; what was discussed; & are there plans for any future meetings.
When Minister last met a representative from Eli Lilley & what was discussed.
When Minister last met a representative from Eli Lilley & what was discussed.
What information is there as to whether any of doctors who prescribed Opren to individual patients after its product licence was withdrawn were participating in research programmes sponsored by Eli Lilly; how many people were given Opren, after its product licence was withdrawn, on a named person basis. - (Holding...
What information is there as to whether any of doctors who prescribed Opren to individual patients after its product licence was withdrawn were participating in research programmes sponsored by Eli Lilly; how many people were given Opren, after its product licence was withdrawn, on a named person basis. - (Holding...
To give medicinal products made by Eli Lilly & its subsidiaries which currently have product licences from DHSS & to indicate which can be purchased without prescription. - Includes list. (Holding answer 23 Feb 1988)
To give medicinal products made by Eli Lilly & its subsidiaries which currently have product licences from DHSS & to indicate which can be purchased without prescription. - Includes list. (Holding answer 23 Feb 1988)
To give details of drugs supplied to the NHS by Eli Lilley.
To give details of drugs supplied to the NHS by Eli Lilley.
To prevent NHS purchasing any of Eli Lilly's drugs except those which are not replaceable.
To prevent NHS purchasing any of Eli Lilly's drugs except those which are not replaceable.
Whether Committee on Safety of Medicines carried out any investigation into circumstances surrounding Eli Lilleys failure to report deaths attributed to Opren to USA Food & Drug Administration & whether Eli Lilley indicated to Committee prior to launch of Opren that drug would cause particular problems for elderly people taking...
Whether Committee on Safety of Medicines carried out any investigation into circumstances surrounding Eli Lilleys failure to report deaths attributed to Opren to USA Food & Drug Administration & whether Eli Lilley indicated to Committee prior to launch of Opren that drug would cause particular problems for elderly people taking...
How many drugs are supplied to NHS by firm Eli Lilley - Includes ref to Association of British Pharmaceutical Industry data sheet compendium 1986-87 in Scientific & Defence Section of Library
How many drugs are supplied to NHS by firm Eli Lilley - Includes ref to Association of British Pharmaceutical Industry data sheet compendium 1986-87 in Scientific & Defence Section of Library